paper reviews the acquisition of Medco Medco Containment Services‚ Inc. (Medco) by Merck & Company (Merck) and cites reasons for acquisition of Medco. Merck’s acquisition of Medco represents a $6.6 billion bet on where the future of the pharmaceutical industry lies (Nichols‚ 1994). In today’s managed-care environment‚ Vagelos (CEO of Merck in 1993) argues‚ the company that best controls the information flow from doctor to patient to pharmacist to plan sponsor has the greatest chance
Premium Pharmacology Pharmaceutical industry Pharmacy
a flourishing research-driven pharmaceutical company‚ which discovers‚ develops‚ manufacturers‚ and promotes an extensive variety of human and animal health products. Although Merck is one of the biggest pharmaceutical companies of the world‚ they still come across problems today while striving to sustain a lead against its competition. Merck has achieved success with its lengthy history of breakthrough drugs and the development of three significant pharmaceutical products: antibiotics‚ vitamins
Premium Human resource management Pharmaceutical industry Human resources
Company History In 1935‚ Dr Khwaja Abdul Hamied set up The Chemical‚ Industrial & Pharmaceutical Laboratories‚ which came to be popularly known as Cipla. He gave the company all his patent and proprietary formulas for several drugs and medicines‚ without charging any royalty. On August 17‚ 1935‚ Cipla was registered as a public limited company with an authorized capital of Rs 6 lacs. Cipla was officially opened on September 22‚ 1937 when the first products were ready for the market. July 4‚ 1939
Premium Pharmacology Pharmaceutical drug
their products and the company doesn’t receive any profits from generic drugs. The company still wants people to have communication with their doctors in order to receive the medications that they need. The company believes that the drawbacks of pharmaceutical price controls to help control rising costs far outweigh any potential benefits. The company asks that policy makers follow certain guidelines which are individual patient needs and the physician-patient relationship must be at the center of the
Premium Medicine Pharmacology Generic drug
eliminate the regulatory pressure on prices (ii) abolish the conditions that favour the practices of patent linkage‚ (iii) create incentives for doctors to prescribe generic medicines‚ (iv) implement a system for pharmacy remuneration based on pharmaceutical act fee or regressive margins‚ (v) create greater differentiation with regard to patients co-payment towards the option of using a more expensive branded medicine instead of a cheaper generic medicine. Bibliography [1] – EGA‚ “How to Increase
Premium Pharmaceutical industry Food and Drug Administration Pharmacy
Application of statistics in Pharmaceutical industry * * * Bookmark Although the advancement of medicine has prolonged and improved the life of many people over the years‚ it is important to remember that it is not an exact science. While some treatments do seem to offer a complete ’cure’ for any particular ailment universally‚ the vast majority of medicinal treatments do not. As such‚ it is important that statistics are used in medicine in order to justify the development and subsequent
Premium Obesity Metabolic syndrome
tickets‚ etc (source 1 #2) 2. Problems in the workplace (NC 3 & 4) C. Treatments available Topic sentence: Treatments for alcoholism are available such as rehabilitation care‚ pharmaceutical treatment‚ and various support group meetings. 1. Rehab centers 2. Pharmaceutical treatment 3. Support groups D. Prevention against alcoholism Topic sentence: Drinking in moderation and taking into account alcohol laws and regulations can act as prevention
Premium Alcohol Cancer Alcohol abuse
GlaxoSmithKline 1. Who are the stakeholders in this case? Which are primary‚ and which are secondary? What influence do they have? Stakeholders for GlaxoSmithKline include the following: Employees; stockholders; creditors; suppliers; customers (both prescribing physicians and end users); retailers (domestically and internationally); activist groups (such as the Minnesota Senior Federation‚ the National Association of the Terminally Ill‚ the Coalition for Access to Affordable Prescription
Premium Pharmacology Pharmaceutical industry Food and Drug Administration
Analysis of Indian Pharmaceutical Industry Dr. Reddy Laboratories Table of Contents Acknowledgement 4 1. Industry Analysis 5 1.1 Porter’s Five Forces Analysis 5 2. DRL’s Present Strategy 6 2.1Riding on Generics 6 2.2Focusing on depth rather than breadth 7 2.3 Leveraging strategic partnerships to reduce risk and investment 8 2.4 Para IV filings 9 2.5 Focusing on selected therapeutic areas 9 3. Key Issues faced by DRL 10 3.1 Poor positioning in India 10 3.2 Russian Opportunity
Premium Generic drug Pharmaceutical industry
the provision of pharmaceutical services from a distance. Telepharmacy expands access to quality health care to communities nationwide‚ primarily in rural‚ medically-underserved areas.[1] Telepharmacy is something that could greatly improve and advance the heath care word not only for providers but also for patients. Telepharmacy however has many legal and privacy issues to resolve before it can become an established part of health care. Due to the high regulations on pharmaceuticals from federal and
Premium Pharmacy Pharmacology Health care